Kai Tai Fiber Composite Conductive Fiber Industrialization Project Started

Ketedt concentrates the production of a large number of China textile mills.

The outstanding talents of the new fiber, and invested by the China Textile Science Research Institute about 100 million yuan, set up a wholly-owned subsidiary to implement the "3400 tons" series of composite conductivity.

Project.

Special Fiber Technology Co., Ltd. annual production of 3400 tons of series of composite conductive fiber industrialization project held the launching ceremony.

The project covers an area of more than 40 mu, a fixed asset investment of 82 million 742 thousand yuan, an annual average output value of 215 million 306 thousand yuan, a planned construction of 2 years, and an investment recovery period (including construction period) for 4.83 years.

Related links:

At present, the performance of medical and sanitary textiles in China shows a variety of development trends. Anti virus, anti penetration, high barrier, antistatic, lightweight, ultra-thin comfort, good ventilation, no stimulation, degradation and so on become the product characteristics.

Products from simple personal hygiene materials gradually developed into medical dressing, surgical hole sheet, surgical clothing, surgical package, surgical suture line and other high-tech products.

In the production process, it has broken through the equipment and technical problems of multi part and multi component melt spinning composite nonwovens. With the finishing technology, the products can be widely used in high-end medical fields such as surgical clothing and isolation clothing to meet the "three resistance" performance.

However, behind these gratifying situations, there are still some problems in the industry: homogenization, uneven product development, weak overall R & D capability, lack of brand awareness and the establishment of high-end product marketing channels, lack of guidance and guarantee mechanisms for national policies and regulations, lack of formulation and standardization of existing product standards and norms, difficulties in application of market development, weak support from local market, lack of qualification certification, and high threshold for market access and clinical trials.

For example, in terms of standards, there are 66 related standards for medical and sanitary textiles in China. Among them, there are 17 items of national standard, 5 items of textile standard (FZ), and 44 items of medical standard (YY), including 44 items of the method standard, 19 items of product standard, 3 items of hygienic standard.

However, the index system is not perfect, there are still relevant standards missing; the standards set in different fields have different emphasis and lack integrity; the high-end products produced in China have no standards to follow; the standard of implantable textiles is blank.

Yu Jianyong, vice president of the Chinese Academy of engineering and vice president of Donghua University, pointed out that the development needs of China's medical and health undertakings will push China's biomedical products and technologies to catch up with the world's advanced level as a whole.

He proposed to strengthen the cooperation of political, research and research, multidisciplinary and technical cross, speed up the development of new biological textile material fiber material system, break through the key technology of high-end biomedical textile materials processing and equipment, strengthen the construction of biomedical textile materials detection and evaluation system, optimize the upgrading and upgrading of Biomedical textile material industry system, and speed up the establishment of a high, medium and low end complete biological textile material product system.

"Medical dressings in our country have already occupied a more stable market share in the international market, and enterprises have a certain ability to withstand pressure and withstand risks in the international market competition.

However, with the saturation of traditional markets such as Europe, America and Japan, and the increase of domestic production costs, there may be more difficulties. "

Li Lingshen suggested that the domestic market will continue to be an important market for medical and health textiles. Enterprises should attach importance to coordination between departments and industries.

Li Lingshen believes that domestic demand in the future is the main driving force for China's medical and health textiles market. The backbone enterprises in the industry have scale, cost and market competitive advantages, and some enterprises have strong R & D capability.

For example, the whole cotton spunlaced nonwovens launched by soundness medical group provides a complete surgical protection solution for the hospital in the whole process of preoperative preparation, intraoperative protection and postoperative care.

In 2005, the technology was independently developed by the soundness group, and has obtained patent certificates in more than 30 countries and regions, including China, the United States, the European Union, Japan, Brazil and India.

How to achieve more industrial innovation? Li Ling Shen suggested that basic research and interdisciplinary communication should be strengthened: the establishment of high-end medical and health textiles major projects, from fiber materials, processing technology to medical engineering, basic research and new product development; strengthening inter departmental coordination, establishing cross departmental coordination and promotion mechanisms and industrial technology Innovation Alliances in product standards, usage standards, R & D and production applications; establishing quality assurance system: setting up different grading indicators and using suggestions, guiding enterprises to carry out R & D, production and promoting virtuous circle according to corresponding standards; strengthening access management: strengthening qualification authentication and quality supervision of circulation links, and circulation organizations should carry out necessary testing and production supervision for products.

Experts attending the meeting believe that the future of medical and health textiles will be toward the direction of biodegradable, composite, functional, minimally invasive and intelligent.

All kinds of new high-tech fibrous raw materials, such as new bio based fibers, polymer nanofiber based biomedical materials and functional fiber materials, are optimized and developed; textile processing technology and biological technology, materials, information and nano technology, such as new generation of biomaterials design and synthesis, nano biomaterials and soft nanotechnology, advanced manufacturing technology and material composite technology, tissue engineering technology, artificial organ, etc., and bio functionalization and bio intellectualization of medical textiles, such as response to human microenvironment, tissue regeneration function and molecular recognition function, are the focus of innovation.